The Latest Breaking News from Aetna

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

Employees should be free to choose their own health care plans, but be given the same contributions from their workplaces, Mark Bertolini argued.

An activist shareholder demanding changes, soaring medical costs, and a $68 billion deal for Aetna.

A trifecta of problems, some that started before she took the top job, ended the reign of one of the most powerful women in American business.

Roger Farah, who worked behind the scenes to right Ralph Lauren and Tory Burch, will become executive chairman at CVS.

The pharmacy chain has announced a major cost-cutting move, and more may be on the way.

CVS Health stock is lower Tuesday on reports the healthcare company is conducting a strategic review of its operations, which includes a potential breakup.

CVS stock is still underwater and CVS Health's board is out of patience, nearly seven years after its Aetna acquisition to build a new model delivering health care out of its stores.

CVS stock rose 2% on Monday, but the healthcare giant has shed over $26 billion in market cap this year.